Ambiq Micro (AMBQ) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
15 Nov, 2025Executive summary
Q3 2025 net sales reached $18.2 million, surpassing guidance but down 10.4% year-over-year, with one of the strongest gross margins to date and a strengthened balance sheet post-IPO.
Strategic pivot to high-value, AI-driven markets accelerated growth, with robust design funnel, increased orders from new and existing customers, and strong Apollo 5 adoption.
Expanded product portfolio with launches of Apollo510 Lite SoC Series and Helio AI Runtime, supporting edge AI growth in wearables, industrial, and AR glasses.
Completed IPO in July 2025, raising $102.7 million and converting all preferred stock to common stock, significantly strengthening cash position.
SPOT platform recognized by Time Magazine as one of the best AI inventions of 2025.
Financial highlights
Q3 2025 net sales were $18.2 million, down 10.4% year-over-year but up 1.6% sequentially; gross margin improved to 44.8% (non-GAAP) and 42.3% (GAAP), up over 10 points year-over-year.
Non-GAAP gross profit was $8.1 million, up 16.8% year-over-year; GAAP gross profit was $7.7 million, up 16.4%.
Non-GAAP net loss attributable to common stockholders was $4 million, improving $1.9 million sequentially and $1.8 million year-over-year; GAAP net loss was $9.0 million.
Ended Q3 with no debt and $146.5 million in cash and equivalents, reflecting IPO proceeds.
Operating expenses (GAAP) were $17.7 million, up from $16.7 million year-over-year; non-GAAP operating expenses were $13.2 million, nearly flat year-over-year.
Outlook and guidance
Q4 2025 net sales expected between $18.5 and $19.5 million, above consensus estimate of $14.2 million and the highest quarterly revenue of 2025.
Non-GAAP loss per share for Q4 expected between $0.44 and $0.34, based on 18.2 million pro forma shares.
Guidance includes higher variable expenses and a $1–1.5 million non-cash OpEx increase due to IP cost reclassification.
Management anticipates continued revenue growth and gross margin expansion in 2026 and 2027, with Atomic platform revenues expected to contribute meaningfully in 2028.
Cash on hand and anticipated cash from operations are expected to be sufficient for at least the next twelve months.
Latest events from Ambiq Micro
- SPOT platform powers edge AI growth, driving market expansion and improved financial performance.AMBQ
Corporate presentation23 Mar 2026 - Q4 gross margin hit 45.5% on record sales; 2026 revenue projected to exceed $100 million.AMBQ
Q4 20255 Mar 2026 - Ultra-low power edge AI chipmaker targets $65M IPO to fund growth in a $21B market.AMBQ
Registration Filing21 Jan 2026 - Edge AI growth, new AI-first products, and market diversification fuel optimism for 2026–2028.AMBQ
UBS’s 2025 Global Technology and AI Conference13 Dec 2025 - SPOT platform powers over 280M edge AI devices, driving growth and high-margin expansion.AMBQ
Investor Presentation4 Dec 2025 - Ultra-low power edge AI chipmaker targets $68.8M IPO to fund growth amid margin gains and market shift.AMBQ
Registration Filing29 Nov 2025 - Ultra-low power edge AI chipmaker targets global growth with NYSE IPO and $76M 2024 sales.AMBQ
Registration Filing29 Nov 2025 - Q2 net sales rose to $17.9M, gross margin improved, and $97.2M was raised in the IPO.AMBQ
Q2 202510 Sep 2025 - SPOT platform powers scalable, low-energy edge AI solutions for high-growth global markets.AMBQ
Investor Presentation1 Aug 2025